Reply to Walker et al

Clinical Infectious Diseases

Volumn 56, Issue 12, 2013, Pages 1846-1847

  Walk, Seth T ^a   Micic, Dejan ^a   Galecki, Andrzej T ^a   Rogers, Mary A M ^a   Washer, Laraine ^a   Newton, Duane W ^a   Malani, Preeti N ^a,b   Young, Vincent B ^a   Aronoff, David M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SEVERITY; ENZYME IMMUNOASSAY; GENE; HUMAN; LETTER; LEUKOCYTE COUNT; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE;

EID: 84877280973     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit099     Document Type: Letter

References (6)

1. Walker AS, Eyre DW, Crook DW, Wilcox M, Peto T. Regarding "Clostridium difficile ribo-type does not predict severe infection". Clin Infect Dis 2013; 56:1845-6.
2. Walk ST, Micic D, Jain R, et al. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis 2012; 55:1661-8.
3. Walk ST, Micic D, Galecki AT, et al. Reply to McDonald. Clin Infect Dis 2012 [Epub ahead of print].
4. Wilcox MH. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection. Clin Microbiol Infect 2012; 18(suppl6):13-20.
5. O'Connor JR, Johnson S, Gerding DN. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009; 136:1913-24.
6. Lawley TD, Clare S, Walker AW, et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 2012; 8:e1002995.